Cargando…
The safety and efficacy of CKD-497 in patients with acute upper respiratory tract infection and bronchitis symptoms: a multicenter, double-blind, double-dummy, randomized, controlled, phase II clinical trial
BACKGROUND: Acute upper respiratory tract infection (AURI) together with acute bronchitis is the most common illness worldwide. Botanical medicines used as expectorants and antitussives have proven to be effective while also having excellent safety margins. We aimed at evaluating the efficacy and sa...
Autores principales: | Ra, Seung Won, Kim, Sun Young, Lim, Yun Young, Park, Shin Jung, Rhee, Chin Kook, Kim, Deog Kyeom, Park, Yong Bum, Lee, Chang Youl, Yoon, Hyoung Kyu, Park, Jeong-Woong, Yoo, Kwang Ha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867795/ https://www.ncbi.nlm.nih.gov/pubmed/33569179 http://dx.doi.org/10.21037/jtd-20-1567 |
Ejemplares similares
-
CAT Score and SGRQ Definitions of Chronic Bronchitis as an Alternative to the Classical Definition
por: Choi, Joon Young, et al.
Publicado: (2019) -
Zabofloxacin versus moxifloxacin in patients with COPD exacerbation: a multicenter, double-blind, double-dummy, randomized, controlled, Phase III, non-inferiority trial
por: Rhee, Chin Kook, et al.
Publicado: (2015) -
Chronic bronchitis is an independently associated factor for more symptom and high-risk groups
por: Choi, Joon Young, et al.
Publicado: (2016) -
Cut-off value of FEV(1)/FEV(6) to determine airflow limitation using handheld spirometry in subjects with risk of chronic obstructive pulmonary disease
por: Hwang, Yong Il, et al.
Publicado: (2021) -
HL301 in the treatment of acute bronchitis: a phase 2b, randomized, double-blind, placebocontrolled, multicenter study
por: Yoon, Sang Won, et al.
Publicado: (2020)